Table 2.
General characteristics of patients with systemic vasculitides and valvular involvement.
| Reference | Sex | Age | ANCA | Vasculitis Classification |
Kidney | ENT | Organ Lungs |
Involvement Eyes |
Skin | Joints | Non-valvular cardiac lesion |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stöllberger [19] | M | 56 | ANCA -, anti-PR3 + | Unknown | Yes | - | - | - | Yes | Yes | - |
| Levine [15] | M | 28 | - | Wegener's granulomatosis | Yes | Yes | Yes | - | - | - | Yes |
| Davenport [6] | M | 19 | c-ANCA +, anti-PR3 + | Wegener's granulomatosis | Yes | Yes | Yes | Yes | Yes | Yes | - |
| M | 53 | c-ANCA +, anti-PR3 + | Wegener's granulomatosis | Yes | - | - | - | - | - | Yes | |
| Grant [10] | M | 32 | c-ANCA + | Wegener's granulomatosis | - | Yes | - | Yes | Yes | Yes | Yes |
| Goodfield [9] | M | 25 | c-ANCA + | Wegener's granulomatosis | - | Yes | Yes | - | - | - | Yes |
| Bruno [4] | F | 63 | ANCA + | Wegener's granulomatosis | - | Yes | Yes | - | - | - | Yes |
| Herbst [12] | F | 56 | ANCA - | Wegener's granulomatosis | - | - | Yes | - | - | Yes | Yes |
| Gerbracht [8] | M | 20 | - | Wegener's granulomatosis | Yes | Yes | Yes | - | - | - | - |
| Greidinger [11] | M | 15 | c-ANCA + | Wegener's granulomatosis | Yes | Yes | Yes | - | Yes | Yes | - |
| Leff [14] | M | 17 | c-ANCA + | Wegener's granulomatosis | - | Yes | Yes | - | Yes | Yes | - |
| Yanda [20] | F | 77 | - | Wegener's granulomatosis | Yes | Yes | Yes | Yes | Yes | - | - |
| Dabbagh [5] | M | 16 | - | Wegener's granulomatosis | Yes | Yes | Yes | Yes | - | - | - |
| Fox [7] | M | 20 | ANCA + | Wegener's granulomatosis | Yes | Yes | Yes | Yes | Yes | Yes | - |
| Anthony [2] | M | 48 | c-ANCA +, anti-PR3 + | Wegener's granulomatosis | - | Yes | Yes | - | Yes | Yes | - |
| Paik [17] | M | 48 | c-ANCA + | Wegener's granulomatosis | - | Yes | Yes | - | - | - | - |
| Mishell [16] | M | 65 | ANCA +, anti-PR3 + | Wegener's granulomatosis | Yes | - | Yes | Yes | Yes | - | - |
| Ramakrishnan [18] | F | 44 | c-ANCA + | Wegener's granulomatosis | Yes | - | Yes | - | - | - | - |
| Attaran [3] | M | 52 | - | Wegener's granulomatosis | - | Yes | - | - | - | - | - |
| Koyalakonda [13] | M | 52 | - | Wegener's granulomatosis | - | Yes | - | Yes | - | - | - |
| Present report | M | 44 | p-ANCA +, anti-PR3 - | Wegener's granulomatosis | - | Yes | - | - | - | - | - |
ANCA: antineutrophil cytoplasmic antibodies; ENT: ear, nose and/or throat involvement; PR3: proteinase-3.